Suppr超能文献

从弗氏志贺菌活疫苗株中获得的多种新型脂质 A 结构。

A variety of novel lipid A structures obtained from Francisella tularensis live vaccine strain.

机构信息

The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Innate Immun. 2012 Apr;18(2):268-78. doi: 10.1177/1753425911401054. Epub 2011 Jun 27.

Abstract

F. tularensis is a Gram-negative coccobacillus that causes tularemia. Its LPS has nominal biological activity. Currently, there is controversy regarding the structure of the lipid A obtained from F. tularensis live vaccine strain (LVS). Therefore, to resolve this controversy, the purification and structural identification of this LPS was crucial. To achieve this, LPS from F. tularensis LVS was acid hydrolyzed to obtain crude lipid A that was methylated and purified by HPLC and the fractions were analyzed by MALDI-TOF MS. The structure of the major lipid A species was composed of a glucosamine disaccharide backbone substituted with four fatty acyl groups and a phosphate (1-position) with a molecular mass of 1505. The major lipid A component contained 18:0[3-O(16:0)] in the distal subunit and two 18:0(3-OH) fatty acyl chains at the 2- or 3-positions of the reducing subunit. Additional variations in the lipid A species include: heterogeneity in fatty acyl groups, a phosphate or a phosphoryl galactosamine at the 1-position, and a hexose at the 4' or 6' position, some of which have not been previously described for F. tularensis LVS. This analysis revealed that lipid A from F. tularensis LVS is far more complex than originally believed.

摘要

弗氏土拉伦菌是一种革兰氏阴性短杆菌,可引起土拉菌病。其 LPS 具有名义上的生物学活性。目前,关于弗氏土拉伦菌活疫苗株(LVS)中获得的脂 A 结构存在争议。因此,为了解决这一争议,LPS 的纯化和结构鉴定至关重要。为此,将弗氏土拉伦菌 LVS 的 LPS 进行酸水解,获得粗制的脂 A,然后通过 HPLC 进行甲基化和纯化,并通过 MALDI-TOF MS 对各馏分进行分析。主要脂 A 种类的结构由带有四个脂肪酸酰基的葡萄糖胺二糖骨架和一个磷酸(1 位)组成,分子量为 1505。主要脂 A 成分在远端亚基中含有 18:0[3-O(16:0)],在还原亚基的 2 位或 3 位含有两个 18:0(3-OH)脂肪酸链。脂 A 种类的其他变化包括:脂肪酸酰基的不均一性、1 位的磷酸或磷酸化半乳糖胺、4'或 6'位的己糖,其中一些在以前的弗氏土拉伦菌 LVS 中并未被描述过。该分析表明,弗氏土拉伦菌 LVS 的脂 A 远比人们最初认为的复杂。

相似文献

1
A variety of novel lipid A structures obtained from Francisella tularensis live vaccine strain.
Innate Immun. 2012 Apr;18(2):268-78. doi: 10.1177/1753425911401054. Epub 2011 Jun 27.
2
Novel modification of lipid A of Francisella tularensis.
Infect Immun. 2004 Sep;72(9):5340-8. doi: 10.1128/IAI.72.9.5340-5348.2004.
5
Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
Microbiology (Reading). 2007 Sep;153(Pt 9):3141-3153. doi: 10.1099/mic.0.2007/006460-0.

引用本文的文献

1
Clinical relevance of abstruse transport phenomena in haemodialysis.
Clin Kidney J. 2021 Dec 27;14(Suppl 4):i85-i97. doi: 10.1093/ckj/sfab183. eCollection 2021 Dec.
2
Lipopolysaccharide Recognition in the Crossroads of TLR4 and Caspase-4/11 Mediated Inflammatory Pathways.
Front Immunol. 2020 Nov 27;11:585146. doi: 10.3389/fimmu.2020.585146. eCollection 2020.
3
From the Outside-In: The Francisella tularensis Envelope and Virulence.
Front Cell Infect Microbiol. 2015 Dec 23;5:94. doi: 10.3389/fcimb.2015.00094. eCollection 2015.
4
Structure and Effects of Cyanobacterial Lipopolysaccharides.
Mar Drugs. 2015 Jul 7;13(7):4217-30. doi: 10.3390/md13074217.
5
TLR2 Signaling is Required for the Innate, but Not Adaptive Response to LVS clpB.
Front Immunol. 2014 Sep 5;5:426. doi: 10.3389/fimmu.2014.00426. eCollection 2014.
7
The atypical lipopolysaccharide of Francisella.
Carbohydr Res. 2013 Aug 30;378:79-83. doi: 10.1016/j.carres.2013.06.015. Epub 2013 Jul 2.
8
Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii.
Antimicrob Agents Chemother. 2013 Oct;57(10):4831-40. doi: 10.1128/AAC.00865-13. Epub 2013 Jul 22.
9
10

本文引用的文献

1
Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge.
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4343-8. doi: 10.1073/pnas.0813411106. Epub 2009 Feb 26.
2
Structure of a novel lipid A obtained from the lipopolysaccharide of Caulobacter crescentus.
Innate Immun. 2008 Feb;14(1):25-37. doi: 10.1177/1753425907087588.
3
Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
Microbiology (Reading). 2007 Sep;153(Pt 9):3141-3153. doi: 10.1099/mic.0.2007/006460-0.
5
The structure and function of Francisella lipopolysaccharide.
Ann N Y Acad Sci. 2007 Jun;1105:202-18. doi: 10.1196/annals.1409.006. Epub 2007 Mar 29.
8
Novel modification of lipid A of Francisella tularensis.
Infect Immun. 2004 Sep;72(9):5340-8. doi: 10.1128/IAI.72.9.5340-5348.2004.
9
Structural analysis of Francisella tularensis lipopolysaccharide.
Eur J Biochem. 2002 Dec;269(24):6112-8. doi: 10.1046/j.1432-1033.2002.03321.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验